| Yanelba Milagros Toribio, MD | |
|
1124 Columbia St Ste 200, Seattle, WA 98104 | |
| (206) 576-6050 | |
| Not Available |
| Full Name | Yanelba Milagros Toribio |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 15 Years |
| Location | 1124 Columbia St Ste 200, Seattle, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043448178 | NPI | - | NPPES |
| 2107565 | Medicaid | WA | |
| 2380036 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 60875741 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Regional Medical Center Everett | Everett, WA | Hospital |
| Swedish Edmonds Hospital | Edmonds, WA | Hospital |
| Swedish Medical Center | Seattle, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cellnetix Pathology Pllc | 8224062971 | 57 |
News Archive
Soligenix, Inc., a development stage biopharmaceutical company, announced today that it has initiated a next generation anthrax vaccine development program pursuant to a field-exclusive option agreement with Harvard University to negotiate a license under patent rights that cover prophylactic uses of a modified anthrax toxin protein.
"Senior United Nations officials on Tuesday made impassioned appeals to the international community to make more resources available to assist millions of people affected by the severe food and nutrition crisis in the Sahel region of West Africa, cautioning that global inaction could lead to a humanitarian disaster," the U.N. News Centre reports.
Researchers at the School of Medicine, Washington University in Saint Louis, USA, showed that the intranasal route of immunization could provide a more efficient protection against SARS-CoV-2 compared to the intramuscular route (i.e. through ‘jabs').
A discovery by scientists at the Salk Institute for Biological Studies might explain why some premature infants fail to respond to existing treatments for a deadly respiratory distress syndrome (RDS) and offers clues for new ways to treat the breathing disorder.
Almost half (47.5%) of women with babies aged six months or younger met the threshold for postnatal depression during the first COVID-19 lockdown, more than double average rates for Europe before the pandemic (23%), finds a new study led by UCL researchers.
› Verified 7 days ago
| Entity Name | Cellnetix Pathology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356310866 PECOS PAC ID: 8224062971 Enrollment ID: O20050921001093 |
News Archive
Soligenix, Inc., a development stage biopharmaceutical company, announced today that it has initiated a next generation anthrax vaccine development program pursuant to a field-exclusive option agreement with Harvard University to negotiate a license under patent rights that cover prophylactic uses of a modified anthrax toxin protein.
"Senior United Nations officials on Tuesday made impassioned appeals to the international community to make more resources available to assist millions of people affected by the severe food and nutrition crisis in the Sahel region of West Africa, cautioning that global inaction could lead to a humanitarian disaster," the U.N. News Centre reports.
Researchers at the School of Medicine, Washington University in Saint Louis, USA, showed that the intranasal route of immunization could provide a more efficient protection against SARS-CoV-2 compared to the intramuscular route (i.e. through ‘jabs').
A discovery by scientists at the Salk Institute for Biological Studies might explain why some premature infants fail to respond to existing treatments for a deadly respiratory distress syndrome (RDS) and offers clues for new ways to treat the breathing disorder.
Almost half (47.5%) of women with babies aged six months or younger met the threshold for postnatal depression during the first COVID-19 lockdown, more than double average rates for Europe before the pandemic (23%), finds a new study led by UCL researchers.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yanelba Milagros Toribio, MD 1124 Columbia St Ste 200, Seattle, WA 98104-2048 Ph: (206) 576-6050 | Yanelba Milagros Toribio, MD 1124 Columbia St Ste 200, Seattle, WA 98104 Ph: (206) 576-6050 |
News Archive
Soligenix, Inc., a development stage biopharmaceutical company, announced today that it has initiated a next generation anthrax vaccine development program pursuant to a field-exclusive option agreement with Harvard University to negotiate a license under patent rights that cover prophylactic uses of a modified anthrax toxin protein.
"Senior United Nations officials on Tuesday made impassioned appeals to the international community to make more resources available to assist millions of people affected by the severe food and nutrition crisis in the Sahel region of West Africa, cautioning that global inaction could lead to a humanitarian disaster," the U.N. News Centre reports.
Researchers at the School of Medicine, Washington University in Saint Louis, USA, showed that the intranasal route of immunization could provide a more efficient protection against SARS-CoV-2 compared to the intramuscular route (i.e. through ‘jabs').
A discovery by scientists at the Salk Institute for Biological Studies might explain why some premature infants fail to respond to existing treatments for a deadly respiratory distress syndrome (RDS) and offers clues for new ways to treat the breathing disorder.
Almost half (47.5%) of women with babies aged six months or younger met the threshold for postnatal depression during the first COVID-19 lockdown, more than double average rates for Europe before the pandemic (23%), finds a new study led by UCL researchers.
› Verified 7 days ago
Afshin Shameli, MD, PHD Pathology Medicare: Medicare Enrolled Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-520-5000 | |
Dr. Mark Robert, Michael Kilgore, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, Box 356100, Seattle, WA 98195 Phone: 206-598-1821 Fax: 206-598-3803 | |
Corinne Lina Fligner, Pathology Medicare: Not Enrolled in Medicare Practice Location: University Of Washington Medical Ctr, 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-598-6400 | |
Jennifer Lapointe, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, C212, Box 356340, Seattle, WA 98195 Phone: 206-543-0065 | |
Lee-ching Zhu, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 125 16th Ave E, Seattle, WA 98112 Phone: 206-326-3000 | |
Dr. Saron Ann Elizabeth Smith, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1229 Madison St Ste 820, Seattle, WA 98104 Phone: 206-576-6507 | |
Mr. Ryuji Ohashi, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: Uwmc Pathology 1959 Ne Pacific, Box356100, Seattle, WA 98195 Phone: 206-598-7858 |